Austrian biotechnology company in Vienna working on precision medicine for chronic wounds, founded as a spin off from Viennese medical research. Develops treatments and diagnostics for hard to heal wounds such as diabetic foot ulcers and venous leg ulcers, based on identifying the molecular drivers of impaired healing and matching patients to therapy, and runs preclinical and clinical development with academic and hospital partners.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen